← Back to Search

Community-Based Interventions for Mental Health

N/A

Recruiting

Led By Victoria K Ngo, PhD

Research Sponsored by City University of New York, School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0, 6, 12, 24 months

Awards & highlights

No Placebo-Only Group

Summary

This trial studies a community program in Harlem that aims to improve mental health services by solving funding and access issues, training local health workers, and coordinating various health and social services. The program also uses common metrics to continuously improve care quality. The goal is to create a sustainable model for providing mental health care within a network of comprehensive services.

Who is the study for?

This trial is for Black and Latino adults aged 18-65 living in Harlem, specifically those from low-income housing or receiving primary care locally. Participants should have a moderate risk for depression, indicated by a PHQ-4 Total Score of 3 or higher.

What is being tested?

The study tests the Harlem Strong Community Mental Health Collaborative's approach to mental health. It involves problem-solving care barriers, training community workers in mental health tasks, coordinating healthcare with social services, and improving data systems for quality care.

What are the potential side effects?

Since this trial focuses on community-based interventions rather than medications, traditional side effects are not applicable. However, participants may experience changes in their stress levels or emotional states due to the nature of mental health interventions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0, 6, 12, 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0, 6, 12, 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 6, 12, 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Anxiety - GAD-7

Depression - PHQ-9

Mental Health Service Linkage

+1 more

Secondary study objectives

Employment Security

Food Insecurity

Housing Security

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Multisector Collaborative Care and TechnologyExperimental Treatment4 Interventions

MCC sites will be randomized to receive an additional technology-based implementation tool to evaluate impact on implementation and consumer outcomes.

Group II: Multisector Collaborative CareExperimental Treatment3 Interventions

Multisector Collaborative Care (MCC) Model will consist of all resources offered in E\&R and additional trainings on skills related to working in a multisectoral team, care navigation, syndemic risks and coordination of services related to MH, social services, and health care.

Group III: Education and ResourcesActive Control1 Intervention

Education and Resources (E\&R) involves online training through the E-Hub on delivery of basic MH task-shifting skills, such as screening, psychoeducation, and referral to MH care. A community directory along with training on community resources will be made available to all participants. Specifically, we will recommend that those identified to have common MH problems (PHQ-4≥3) are offered a single two-hour zoom-based group psychoeducation session about depression and anxiety, COVID-19 impact on MH, wellness and self-care skills, and directory of Harlem-based MH services and other community resources. Participants exhibiting higher level needs are referred to MH specialists.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Learning Collaborative

2014

N/A

~20

Supervision

2010

Completed Phase 2

~330